Our talented team have experience in supporting clients across a wide range of therapy and key market access areas.
Rare Diseases (Orphan & Ultra-Orphan)
Generic and Biosimilar Introduction & Defence
Hospital Specialist Medicine
Devices & Diagnostics
Proud to work with a wide range of clients including...
Chief Executive Officer
Dorinda is a scientist by training with a PhD in Haematology. Her market access consultancy expertise, incorporating UK, EU and global pricing and reimbursement work, has been gained while working for Parexel and Policy Matters as well as for her own UK specialist consultancy.
Prior to consultancy Dorinda worked at Novartis where she held a variety of roles including Head of Oncology and Dermatology, Head of Business Intelligence and Director of Healthcare Marketing for Novartis UK as well as country manager for Sandoz in Ireland.
Her therapy area expertise ranges from oncology and haematology through to organ transplantation, neuroscience and mental health. More recently Dorinda graduated from the London School of Economics and Social Science with an MSc in Health Economics, Policy and Management.
Cathy is Managing Director at OPEN Access Consulting. She has worked extensively in market access consultancy, delivering a wide range of market access programmes and has expertise in developing value strategies and ensuring their effective communication and dissemination to all stakeholders.
Prior to consulting Cathy worked for Roche where, latterly, she was responsible for developing the strategy and delivery of implementation tools for the managed entry and market access activity for the Roche oncology and hospital specialist products.
OPEN Access Consulting is part of OPEN Health; a world-class healthcare communications and
market access group, made up of specialist, best-in-class businesses that are
each experts in their respective fields.